
About Sphere Sight
Sphere Sight is a Healthcare company based in Chennai (India) founded in 2018. It creates advanced eye care technology for diagnosing and treating ocular disorders. It operates on a B2B model. Its Indian entity Sphere Sight Private Limited reported revenue of βΉ1.3 Lakh. Sphere Sight offers products and services including Casiloscope, Accure Pro, and Myopia Rx. Its focus areas include Health and Wellness Tech, Medical Devices, Ophthalmic Diagnostics and Eye Examination Tools. Its competitors include Forus Health, Ibis Vision, Smart Optometry, Siloton and Health Intelligence and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
Sphere Sight Private Limited is an RD firm based in Chennai, India, focused on simplifying eye testing through innovative technology. They design tools like Casiloscope for anterior segment diagnostics and Accure Pro for visual acuity measurement, using machine learning to detect disorders. Their products, including Myopia Rx for children, undergo rigorous testing and are supported by global clinicians to address preventable blindness effectively.
- Headquarters Chennai, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website spheresight.in
- Legal Name Sphere Sight Private Limited
- Date of Incorporation 10 Mar, 2018
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹1.3 Lakh
FY 2023 · +3% YoY
Associated legal entities of Sphere Sight
Sphere Sight operates through Sphere Sight Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sphere Sight Private Limited CIN U33309TN2018PTC121309 | Active | 10 Mar 2018 | Chennai, Tamil Nadu | ₹0.0 Cr | – | 2 | View details |
Products & Services of Sphere Sight
Sphere Sight offers a comprehensive portfolio of products and services, including Casiloscope, Accure Pro, and Myopia Rx.
Examines anterior segment and detects ocular disorders using machine learning.
Measures visual acuity for outdoor eye camps and patient screening.
Provides diagnostics and treatment for myopia in children under 16.
Board of directors of Sphere Sight Private Limited (Sphere Sight)
Sphere Sight Private Limited is the primary company behind Sphere Sight. The board of Sphere Sight Private Limited currently have 2 directors; the longest-serving is Venkadesan Mohan, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkadesan Mohan DIN 08082762 | Director | 10 Mar 2018 | 8 yrs 7 mo | Sphere Sight Private Limited |
| Vijaya Venkatesan DIN 08082783 | Director | 10 Mar 2018 | 8 yrs 7 mo | Sphere Sight Private Limited |
Financials of Sphere Sight
Figures of Sphere Sight Private Limited, the primary company behind Sphere Sight, for FY 2023. Revenue was ₹1.3 Lakh (+3% year on year). Revenue has grown at a compounded annual rate of +5% over three years.
- ₹1.3 LakhRevenue · FY 2023 · +3% YoY
- ₹1 LakhPaid-up capital
- +5%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Sphere Sight Private Limited are on its company page.
Detailed financial statements for Sphere Sight
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Sphere Sight
Sphere Sight has 10 listed competitors in our database, 6 of them funded. They include Forus Health, Ibis Vision, Smart Optometry, Siloton and Health Intelligence, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| forushealth.com | 2010 | Bengaluru, India | $18.12M | 171 | Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | |
| ibis.vision | 2014 | Glasgow, United Kingdom | $12.23M | 2 | Cloud-based vision testing software is offered for the optical industry. | |
| smart-optometry.com | 2015 | Idrija, Slovenia | $363,720 | – | A platform for optometry screening and diagnostic tools is provided. | |
| siloton.com | 2020 | Bristol, United Kingdom | $1.86M | – | Digital eye imaging and OCT solutions are provided for providers. | |
| health-intelligence.com | 1996 | Sandbach, United Kingdom | – | 463 | Software and services for risk stratification, diabetic eye screening, and population based health data analytics | |
| alfaleus.in | 2018 | Hyderabad, India | $58,568 | – | A portable VR-based device for visual field testing is offered. | |
| ocudocmobile.com | 2013 | Columbus, United States | $4.9M | – | An online eye diagnosis app is offered for healthcare professionals. | |
| ulmamedicaltechnologies.com | 2017 | Onati, Spain | – | – | AI-powered diagnostic solutions for healthcare are developed and optimized. | |
| emagix.ca | 2016 | Halifax, Canada | – | – | Provider of diagnostic image analysis platform | |
| lucydx.co | 2021 | Middletown, United States | – | – | Digital retinal eye disease diagnostic tool for providers |
Detailed competitors of Sphere Sight
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
10 companies that operate in the same segment as Sphere Sight (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sphere Sight
Sphere Sight was founded in 2018.
Sphere Sight is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
The primary company behind Sphere Sight, Sphere Sight Private Limited, reported revenue of βΉ1.3 Lakh for FY 2023, up 3% year on year.
Sphere Sight Private Limited is an RD firm based in Chennai, India, focused on simplifying eye testing through innovative technology. They design tools like Casiloscope for anterior segment diagnostics and Accure Pro for visual acuity measurement, using machine learning to detect disorders. Their products, including Myopia Rx for children, undergo rigorous testing and are supported by global clinicians to address preventable blindness effectively.
Sphere Sight's top competitors include Forus Health, Ibis Vision and Siloton.
Sphere Sight offers Casiloscope, Accure Pro, and Myopia Rx.
Sphere Sight operates through Sphere Sight Private Limited.
The legal entities of Sphere Sight currently have 2 directors, including Venkadesan Mohan, Vijaya Venkatesan.